Internal medicine journal
-
Internal medicine journal · Feb 2022
Evidence-practice gaps in P2Y12 inhibitor use after hospitalisation for acute myocardial infarction: findings from a new population-level data linkage in Australia.
P2Y12 inhibitor therapy is recommended for 12 months in patients hospitalised for acute myocardial infarction (AMI) unless the bleeding risk is high. ⋯ Post-hospitalisation use of P2Y12 inhibitor therapy in AMI patients is low and varies substantially by hospital of discharge. Our findings suggest strategies addressing both health system (hospital and physician) and patient factors are needed to close this evidence-practice gap.
-
Internal medicine journal · Feb 2022
Automated information extraction from free-text medical documents for stroke key performance indicators: a pilot study.
Automated information extraction might be able to assist with the collection of stroke key performance indicators (KPI). The feasibility of using natural language processing for classification-based KPI and datetime field extraction was assessed. ⋯ The datetime field extraction method was successful in 29 of 43 (67.4%) cases. Further studies are indicated.
-
Internal medicine journal · Feb 2022
Hospitalisation and associated costs of gastrointestinal bleeding from primary prevention aspirin use in South Australia: a retrospective case series analysis.
We assessed hospitalisations for gastrointestinal bleeding directly related to primary prevention aspirin in lower risk patients for a 6-month period in three South Australian hospitals. Those with related underlying pathology or concurrent causative medication were excluded. ⋯ Mean hospital admission cost was $6769 (95% confidence interval $5198-$8340), with projected state and national annual costs of $0.57 and $8.12 million respectively. In light of recent guideline changes, clinicians need to vigorously assess the need for primary prevention aspirin.
-
Internal medicine journal · Feb 2022
Survey study of trends in adult nephrology advanced training in Australia and New Zealand.
There has been considerable growth in nephrology advanced trainee numbers in Australia and New Zealand, with uncertain effects on clinical experience, competence and employment outcomes. ⋯ Trainees and nephrologists in Australia and New Zealand are currently satisfied with their training in most aspects of nephrology; however, some clinical experiences are perceived as inadequate and early career paths after advanced training are increasingly diverse.
-
Internal medicine journal · Feb 2022
Regional Victoria physician subspecialty training and workforce: the current state of play.
This report outlines the advantages and barriers to working and training in regional Victoria with an aim to provide future researchers with data points to address the maldistribution of medical specialists in regional Australia. Some of the advantages are positive job satisfaction, collegiality and good work-life balance, while increased workload and insufficient number of specialists were reported as disadvantages.